Enanta Pharmaceuticals, Inc. · NASDAQ:ENTA
Enanta Pharmaceuticals, Inc. shareholders
As of Jun 30, 2026, 118 institutions reported holding Enanta Pharmaceuticals, Inc., 93.6% of its shares. Largest: Jupiter Topco LLC, BlackRock and Krensavage Asset Management, LLC. New holders, exits, insiders and big stakes, each with its filing.
| Holder | Shares | % of Enanta Pharmaceuticals, Inc. | Change | Filed |
|---|---|---|---|---|
| Jupiter Topco LLC | 3.65M | 12.5% | first report | Aug 14, 2026 |
| BlackRock | 3.24M | 11.1% | +141K | Aug 7, 2026 |
| Krensavage Asset Management, LLC | 2.87M | 9.8% | no change | Aug 14, 2026 |
| Vanguard | 2.42M | 8.3% | +93,567 | Aug 13, 2026 |
| Farallon Capital Management, L.L.C. | 2.42M | 8.3% | −454K | Aug 14, 2026 |
| Deep Track Capital, LP | 1.44M | 5.0% | −513K | Aug 14, 2026 |
| ADAR1 Capital Management, LLC | 1.34M | 4.6% | +1.29M | Aug 14, 2026 |
| Spruce Street Capital LP | 1.09M | 3.7% | +156K | Aug 13, 2026 |
| Acadian Asset Management LLC | 1.08M | 3.7% | +198K | Aug 13, 2026 |
| Geode Capital | 777K | 2.7% | +51,573 | Aug 12, 2026 |